# Capital Bancorp Inc: financial statements, quarterly

CBNK · Nasdaq · CIK 1419536 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cbnk.md) · [Financials](/companies/cbnk/financials.md) · [Filings](/companies/cbnk/filings.md) · [Insiders](/companies/cbnk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cbnk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $m | [(1.0)](/filings/0001419536-24-000030.md) | [(1.5) d](/filings/0001419536-25-000047.md) | [(0.9)](/filings/0001419536-25-000063.md) | [(0.8)](/filings/0001419536-25-000081.md) | [(1.0)](/filings/0001419536-25-000111.md) | [(1.0) d](/filings/0001419536-25-000047.md) | [(0.9)](/filings/0001419536-25-000063.md) | [(0.9)](/filings/0001419536-25-000081.md) | [(0.9)](/filings/0001419536-25-000111.md) | not reported | not reported | not reported |
| Interest expense | $m | [10.9](/filings/0001419536-23-000125.md) | [12.1 d](/filings/0001628280-24-011467.md) | [13.4](/filings/0001628280-24-022477.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [3.0](/filings/0001419536-24-000030.md) | [2.2 d](/filings/0001419536-25-000047.md) | [2.1](/filings/0001419536-25-000063.md) | [2.7](/filings/0001419536-25-000081.md) | [2.8](/filings/0001419536-25-000111.md) | [3.2 d](/filings/0001419536-26-000073.md) | [4.4](/filings/0001419536-26-000100.md) | [4.0](/filings/0001419536-26-000112.md) | [4.8](/filings/0001419536-25-000111.md) | [4.6 d](/filings/0001419536-26-000073.md) | [3.9](/filings/0001419536-26-000100.md) | [4.2](/filings/0001419536-26-000112.md) |
| Net income | $m | [9.8](/filings/0001419536-24-000030.md) | [9.0 d](/filings/0001419536-25-000047.md) | [6.6](/filings/0001419536-25-000111.md) | [8.2](/filings/0001419536-25-000111.md) | [8.7](/filings/0001419536-25-000111.md) | [7.5 d](/filings/0001419536-26-000073.md) | [13.9](/filings/0001419536-26-000112.md) | [13.1](/filings/0001419536-26-000112.md) | [15.1](/filings/0001419536-25-000111.md) | [15.0 d](/filings/0001419536-26-000073.md) | [12.0](/filings/0001419536-26-000112.md) | [14.3](/filings/0001419536-26-000112.md) |
| Diluted EPS | $ per share | [0.70](/filings/0001419536-24-000030.md) | not reported | [0.47](/filings/0001419536-25-000063.md) | [0.59](/filings/0001419536-25-000081.md) | [0.62](/filings/0001419536-25-000111.md) | not reported | [0.82](/filings/0001419536-26-000100.md) | [0.78](/filings/0001419536-26-000112.md) | [0.89](/filings/0001419536-25-000111.md) | not reported | [0.73](/filings/0001419536-26-000100.md) | [0.87](/filings/0001419536-26-000112.md) |
| Basic EPS | $ per share | [0.70](/filings/0001419536-24-000030.md) | not reported | [0.47](/filings/0001419536-25-000063.md) | [0.59](/filings/0001419536-25-000081.md) | [0.62](/filings/0001419536-25-000111.md) | not reported | [0.84](/filings/0001419536-26-000100.md) | [0.79](/filings/0001419536-26-000112.md) | [0.91](/filings/0001419536-25-000111.md) | not reported | [0.74](/filings/0001419536-26-000100.md) | [0.87](/filings/0001419536-26-000112.md) |

- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [2,272](/filings/0001419536-24-000030.md) | [2,226](/filings/0001419536-25-000047.md) | [2,324](/filings/0001419536-25-000063.md) | [2,439](/filings/0001419536-25-000081.md) | [2,561](/filings/0001419536-25-000111.md) | [3,207](/filings/0001419536-26-000073.md) | [3,350](/filings/0001419536-26-000100.md) | [3,389](/filings/0001419536-26-000112.md) | [3,389](/filings/0001419536-25-000111.md) | [3,606](/filings/0001419536-26-000112.md) | [3,808](/filings/0001419536-26-000100.md) | [3,890](/filings/0001419536-26-000112.md) |
| Total liabilities | $m | [2,030](/filings/0001419536-23-000125.md) | [1,971](/filings/0001419536-25-000047.md) | [2,065](/filings/0001628280-24-022477.md) | [2,171](/filings/0001419536-24-000022.md) | [2,281](/filings/0001419536-24-000030.md) | [2,852](/filings/0001419536-26-000073.md) | [2,980](/filings/0001419536-25-000063.md) | [3,009](/filings/0001419536-25-000081.md) | [2,995](/filings/0001419536-25-000111.md) | [3,204](/filings/0001419536-26-000112.md) | [3,400](/filings/0001419536-26-000100.md) | [3,468](/filings/0001419536-26-000112.md) |
| Shareholders' equity | $m | [243](/filings/0001419536-24-000030.md) | [255](/filings/0001419536-26-000073.md) | [259](/filings/0001419536-25-000111.md) | [268](/filings/0001419536-25-000111.md) | [280](/filings/0001419536-25-000111.md) | [355](/filings/0001419536-26-000112.md) | [370](/filings/0001419536-26-000112.md) | [380](/filings/0001419536-26-000112.md) | [395](/filings/0001419536-25-000111.md) | [402](/filings/0001419536-26-000112.md) | [409](/filings/0001419536-26-000112.md) | [422](/filings/0001419536-26-000112.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [22.5 d](/filings/0001419536-24-000030.md) | [6.2 d](/filings/0001419536-25-000047.md) | [(3.4)](/filings/0001419536-25-000063.md) | [12.9 d](/filings/0001419536-25-000081.md) | [(0.5) d](/filings/0001419536-25-000111.md) | [25.9 d](/filings/0001419536-26-000073.md) | [22.6](/filings/0001419536-26-000100.md) | [(4.2) d](/filings/0001419536-26-000112.md) | [32.9 d](/filings/0001419536-25-000111.md) | [18.5 d](/filings/0001419536-26-000073.md) | [21.8](/filings/0001419536-26-000100.md) | [(5.0) d](/filings/0001419536-26-000112.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [1.1 d](/filings/0001419536-24-000030.md) | [1.1 d](/filings/0001419536-25-000047.md) | [1.1](/filings/0001419536-25-000063.md) | [1.1 d](/filings/0001419536-25-000081.md) | [1.4 d](/filings/0001419536-25-000111.md) | [1.7 d](/filings/0001419536-26-000073.md) | [1.7](/filings/0001419536-26-000100.md) | [1.7 d](/filings/0001419536-26-000112.md) | [2.0 d](/filings/0001419536-25-000111.md) | [2.0 d](/filings/0001419536-26-000073.md) | [2.0](/filings/0001419536-26-000100.md) | [2.0 d](/filings/0001419536-26-000112.md) |
| Share repurchases | $m | [1.9 d](/filings/0001419536-24-000030.md) | [1.9 d](/filings/0001419536-25-000047.md) | [1.4](/filings/0001419536-25-000063.md) | [0.0 d](/filings/0001419536-25-000081.md) | [0.0 d](/filings/0001419536-25-000111.md) | [0.0 d](/filings/0001419536-26-000073.md) | [0.6](/filings/0001419536-26-000100.md) | [2.9 d](/filings/0001419536-26-000112.md) | [(0.3) d](/filings/0001419536-25-000111.md) | [8.6 d](/filings/0001419536-26-000073.md) | [3.6](/filings/0001419536-26-000100.md) | [0.0 d](/filings/0001419536-26-000112.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [14.4](/filings/0001419536-23-000125.md) | [14.3](/filings/0001628280-24-022477.md) | [14.1](/filings/0001419536-24-000022.md) | [14.0](/filings/0001419536-24-000030.md) | [13.9](/filings/0001419536-25-000063.md) | [13.9](/filings/0001419536-25-000081.md) | [14.0](/filings/0001419536-25-000111.md) | [16.9](/filings/0001419536-26-000100.md) | [16.8](/filings/0001419536-26-000112.md) | [16.8](/filings/0001419536-25-000111.md) | [16.4](/filings/0001419536-26-000100.md) | [16.4](/filings/0001419536-26-000112.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,290,456 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0001419536-26-000112.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.